Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol
Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testin...
Similar Items
-
Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context
by: Arianis Tatiana Ramírez, et al.
Published: (2023-10-01) -
Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study
by: Mary Luz Rol, et al.
Published: (2022-11-01) -
HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile Autotoma vaginal para detección de virus del papiloma humano en mujeres no adherentes a tamizaje con Papanicolaou en Chile
by: Javiera Léniz, et al.
Published: (2013-04-01) -
High sensitivity and specificity rates of cobas® HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting.
by: Laura Alicia Fleider, et al.
Published: (2023-01-01) -
Validation of an IGF1 Screening Method for Retinopathy of Pre-maturity
by: Alejandro Pérez-Muñuzuri, et al.
Published: (2020-12-01)